DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 133 filers reported holding DIPLOMAT PHARMACY INC in Q2 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $50,000 | -19.4% | 10,231 | 0.0% | 0.00% | – |
| Q2 2019 | $62,000 | +5.1% | 10,231 | 0.0% | 0.00% | – |
| Q1 2019 | $59,000 | -91.3% | 10,231 | -61.3% | 0.00% | -100.0% |
| Q2 2018 | $676,000 | +333.3% | 26,459 | +240.7% | 0.00% | +100.0% |
| Q4 2017 | $156,000 | +12.2% | 7,765 | +56.9% | 0.00% | 0.0% |
| Q3 2016 | $139,000 | -62.6% | 4,950 | -61.8% | 0.00% | -66.7% |
| Q3 2015 | $372,000 | – | 12,952 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENMEDE TRUST CO NA | 420 | $1,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |